01416nam 2200385Ia 450 991069888000332120090507132812.0(CKB)5470000002397063(OCoLC)320456955(EXLCZ)99547000000239706320090507d2007 ua 0enguran|||||||||txtrdacontentcrdamediacrrdacarrierGuidance for industry[electronic resource] manufacturing biological intermediates and biological drug substances using spore-forming microorganismsRockville, MD :U.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Biologics Evaluation and Research,[2007]ii, 14 pages digital, PDF fileTitle from PDF title page (viewed on May 7, 2009)."September 2007".Guidance for industry Intermediates (Chemistry)Sporeforming bacteriaUnited StatesPharmaceutical biotechnologyUnited StatesIntermediates (Chemistry)Sporeforming bacteriaPharmaceutical biotechnologyCenter for Biologics Evaluation and Research (U.S.)GPOGPOBOOK9910698880003321Guidance for industry3434577UNINA